Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study.
Yuxiao LiuXiaofan GuoPeijun XuYuning SongJing HuangXingyun ChenWenbo ZhuBaocun SunSong GaoPublished in: Cancer biology & medicine (2024)
A 5-fluorouracil- or gemcitabine-based combined regimen was shown to be as effective as a single 5-fluorouracil or gemcitabine regimen as second-line therapy for patients with APC.